IRCT20141007019432N8尚未招募2 期
Evaluation of topical adjuvant treatment of psoriasis with recombinant Epidermal Growth Factor to control the e-regulation of the Epidermal Growth Factor Receptor (EGFR): clinical trial phase 2
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Informed consent
- •Mild to moderate psoriasis (all types) with active plaques on both body sides accessible for self product application
- •Age 18-60 years
排除标准
- •Systemic psoriasis treatment 3 months prior and during the study
- •Local psoriasis treatment on the investigational sites in the last 30 days or during the study
- •Known hypersensitivity or allergy to the EGF containing product and/or to Vaseline/10% salicylic acid
- •History of malignant disease Other clinically relevant concomitant disease state Participation in another investigational drug study in the last 30 days
研究者
相似试验
进行中（未招募）
不适用
Determination of antipsoriatic efficacy of topical paroxetine hydrochloride ointments in a psoriasis plaque testhealthy subjectsEUCTR2004-004740-51-DEAgis Industries (1983) ltd.15
进行中（未招募）
不适用
Determination of antipsoriatic efficacy of topical formulations and comparison to a brand medication and placebo in a psoriasis plaque testMale or female subjects aged 18 to 64 are eligible for the study insofar that they suffer from chronic plaque type psoriasis.EUCTR2005-004859-35-DEG&W Laboratories, Inc.15
进行中（未招募）
不适用
Determination of antipsoriatic efficacy of topical formulations in a psoriasis plaque test - Psoriasis plaque testmale or female subjects with chronic plaque type psoriasisEUCTR2006-001186-42-DEAstion Danmark A/S15
已完成
不适用
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque TestPsoriasis VulgarisNCT00236171Technische Universität Dresden14
尚未招募
2 期
Anti-psoriatic Activity of a Novel Polyherbal UNIM 401 FormulatioCTRI/2023/07/055205Central council for Research in Unani Medicine